{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:24:52Z","timestamp":1785770692909,"version":"3.56.0"},"reference-count":90,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Estonian Science Council Grant","award":["IUT2-3"],"award-info":[{"award-number":["IUT2-3"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Alzheimer's disease (AD) is a neurodegenerative disorder with no cure. Limited treatment options available today do not offer solutions to slow or stop any of the suspected causes. The current medications used for the symptomatic treatment of AD include memantine and acetylcholine esterase inhibitors. Some studies suggest that melatonin could also be used in AD patients due to its sleep-improving properties.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this study, we evaluated whether a combination of memantine with melatonin, administered for 32 days in drinking water, was more effective than either drug alone with respect to A\u03b2 aggregates, neuroinflammation and cognition in the double transgenic APP\/PS1 (5xFAD) mouse model of AD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>In this study, chronic administration of memantine with melatonin improved episodic memory in the object recognition test and reduced the number of amyloid aggregates and reactive microgliosis in the brains of 5xFAD mice. Although administration of memantine or melatonin alone also reduced the number of amyloid aggregates and inflammation in brain, this study shows a clear benefit of the drug combination, which had a significantly stronger effect in this amyloid-dominant mouse model of AD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our data suggest considerable potential for the use of memantine with melatonin in patients with AD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jphp.13165","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T07:37:42Z","timestamp":1568792262000},"page":"1695-1705","source":"Crossref","is-referenced-by-count":34,"title":["Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimer's disease"],"prefix":"10.1093","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8060-5998","authenticated-orcid":false,"given":"Monika","family":"J\u00fcrgenson","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Institute of Biomedicine and Translational Medicine, University of Tartu , Tartu,","place":["Estonia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Zharkovskaja","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Biomedicine and Translational Medicine, University of Tartu , Tartu,","place":["Estonia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aveli","family":"Noortoots","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Biomedicine and Translational Medicine, University of Tartu , Tartu,","place":["Estonia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Morozova","sequence":"additional","affiliation":[{"name":"Mental Health Research Centre , Moscow,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Beniashvili","sequence":"additional","affiliation":[{"name":"Mental Health Research Centre , Moscow,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Zapolski","sequence":"additional","affiliation":[{"name":"Valentech Ltd, Skolkovo Innovation Centre , Moscow,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zharkovsky","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Biomedicine and Translational Medicine, University of Tartu , Tartu,","place":["Estonia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,11,1]]},"reference":[{"key":"2024103012315473900_jphp13165-cit-0001","volume-title":"World Alzheimer Report 2016: Improving Healthcare for People Living with Dementia Coverage, Quality and Costs Now and in the Future","author":"Prince","year":"2016"},{"key":"2024103012315473900_jphp13165-cit-0002","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.278.5337.412","article-title":"Life and death of neurons in the aging brain","volume":"278","author":"Morrison","year":"1997","journal-title":"Science"},{"key":"2024103012315473900_jphp13165-cit-0003","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1741-7015-7-7","article-title":"Recent developments in Alzheimer's disease therapeutics","volume":"7","author":"Rafii","year":"2009","journal-title":"BMC Med"},{"key":"2024103012315473900_jphp13165-cit-0004","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2174\/156720506779025279","article-title":"The role of tau phosphorylation in the pathogenesis of Alzheimer's disease","volume":"3","author":"Mi","year":"2006","journal-title":"Curr Alzheimer Res"},{"key":"2024103012315473900_jphp13165-cit-0005","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A beta oligomers-a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J Neurochem"},{"key":"2024103012315473900_jphp13165-cit-0006","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","article-title":"Intracellular amyloid-beta in Alzheimer's disease","volume":"8","author":"LaFerla","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"2024103012315473900_jphp13165-cit-0007","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-2094-3-30","article-title":"The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease","volume":"3","author":"Wilkinson","year":"2006","journal-title":"J Neuroinflammation"},{"key":"2024103012315473900_jphp13165-cit-0008","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.ajhg.2008.05.001","article-title":"Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome\u2013an autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13","volume":"82","author":"Giunta","year":"2008","journal-title":"Am J Hum Genet"},{"key":"2024103012315473900_jphp13165-cit-0009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.2000.tb05561.x","article-title":"\u201cFatal attractions\u201d of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders","volume":"924","author":"Trojanowski","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"2024103012315473900_jphp13165-cit-0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3233\/JAD-2002-4313","article-title":"Neurofibrillary pathology leads to synaptic loss and not the other way around in Alzheimer disease","volume":"4","author":"Igbal","year":"2002","journal-title":"J Alzheimers Dis"},{"key":"2024103012315473900_jphp13165-cit-0011","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ajpath.2011.05.047","article-title":"Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease","volume":"179","author":"Serrano-Pozo","year":"2011","journal-title":"Am J Pathol"},{"key":"2024103012315473900_jphp13165-cit-0012","first-page":"211","article-title":"Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"3","author":"Hansen","year":"2008","journal-title":"Clin Interv Aging"},{"key":"2024103012315473900_jphp13165-cit-0013","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-148-5-200803040-00008","article-title":"Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians","volume":"148","author":"Qaseem","year":"2008","journal-title":"Ann Intern Med"},{"key":"2024103012315473900_jphp13165-cit-0014","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.neuropharm.2011.01.035","article-title":"Subchronic memantine administration on spatial learning, exploratory activity, and nest building in an APP\/PS1 mouse model of Alzheimer's disease","volume":"60","author":"Filali","year":"2011","journal-title":"Neuropharmacology"},{"key":"2024103012315473900_jphp13165-cit-0015","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s10439-011-0494-z","article-title":"Protection from glutamate-induced excitotoxicity by memantine","volume":"40","author":"Kutzing","year":"2012","journal-title":"Ann Biomed Eng"},{"key":"2024103012315473900_jphp13165-cit-0016","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.euroneuro.2005.06.005","article-title":"Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model","volume":"16","author":"Van Dam","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"2024103012315473900_jphp13165-cit-0017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-079X.2011.00937.x","article-title":"Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin","volume":"52","author":"Rosales-Corral","year":"2012","journal-title":"J Pineal Res"},{"key":"2024103012315473900_jphp13165-cit-0018","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/10715760600936359","article-title":"Chronic melatonin treatment prevents age-dependent cardiac mitochondrial dysfunction in senescence-accelerated mice","volume":"41","author":"Rodr\u0131guez","year":"2007","journal-title":"Free Radic Res"},{"key":"2024103012315473900_jphp13165-cit-0019","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-079X.2008.00580.x","article-title":"Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species","volume":"45","author":"Peyrot","year":"2008","journal-title":"J Pineal Res"},{"key":"2024103012315473900_jphp13165-cit-0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11154-009-9125-5","article-title":"Melatonin formation in mammals: in vivo perspectives","volume":"10","author":"Chattoraj","year":"2009","journal-title":"Rev Endocr Metab Disord"},{"key":"2024103012315473900_jphp13165-cit-0021","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1081\/CBI-100101055","article-title":"Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in Institutionalized demented elderly persons","volume":"17","author":"Mishima","year":"2000","journal-title":"Chronobiol Int"},{"key":"2024103012315473900_jphp13165-cit-0022","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1196\/annals.1356.025","article-title":"Clinical perspectives for the use of melatonin as a chronobiotic and cytoprotective agent","volume":"1057","author":"Cardinali","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"2024103012315473900_jphp13165-cit-0023","first-page":"39","article-title":"Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer's disease","volume":"21","author":"Brusco","year":"2000","journal-title":"Neuro Endocrinol Lett"},{"key":"2024103012315473900_jphp13165-cit-0024","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal amyloid-\u03b2aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J Neurosci"},{"key":"2024103012315473900_jphp13165-cit-0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nbd.2008.10.006","article-title":"Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model","volume":"33","author":"Kimura","year":"2009","journal-title":"Neurobiol Dis"},{"key":"2024103012315473900_jphp13165-cit-0026","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3940(95)11785-U","article-title":"Cerebrospinal fluid and serum concentrations of the N-methyl-d-aspartate (NMDA) receptor antagonist memantine in man","volume":"195","author":"Kornhuber","year":"1995","journal-title":"Neurosci Lett"},{"key":"2024103012315473900_jphp13165-cit-0027","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.104.071027","article-title":"Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease","volume":"311","author":"Minkeviciene","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"2024103012315473900_jphp13165-cit-0028","doi-asserted-by":"crossref","first-page":"e2575","DOI":"10.1371\/journal.pone.0002575","article-title":"Impaired spatial learning strategies and novel object recognition in mice haploinsufficient for the dual specificity tyrosine-regulated kinase-1A (Dyrk1A)","volume":"3","author":"Arqu\u00e9","year":"2008","journal-title":"PLoS One"},{"key":"2024103012315473900_jphp13165-cit-0029","first-page":"e55718","article-title":"Novel object recognition test for the investigation of learning and memory in mice","volume":"126","author":"Lueptow","year":"2017","journal-title":"J Vis Exp"},{"key":"2024103012315473900_jphp13165-cit-0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pbb.2010.07.006","article-title":"Behavioral profile of mice with impaired cognition in the elevated plus-maze due to a deficiency in neural cell adhesion molecule","volume":"96","author":"J\u00fcrgenson","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"2024103012315473900_jphp13165-cit-0031","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/nprot.2006.277","article-title":"Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with congo red histochemical stain","volume":"1","author":"Wilcock","year":"2006","journal-title":"Nat Protoc"},{"key":"2024103012315473900_jphp13165-cit-0032","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.euroneuro.2016.02.015","article-title":"Deficiency of prolyl oligopeptidase in mice disturbs synaptic plasticity and reduces anxiety-like behaviour, body weight, and brain volume","volume":"26","author":"H\u00f6fling","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"2024103012315473900_jphp13165-cit-0033","volume-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2012","edition":"4th"},{"key":"2024103012315473900_jphp13165-cit-0034","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"key":"2024103012315473900_jphp13165-cit-0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/bih.76.2.97.106","article-title":"Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease","volume":"76","author":"Dandrea","year":"2001","journal-title":"Biotech Histochem"},{"key":"2024103012315473900_jphp13165-cit-0036","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1523\/JNEUROSCI.2868-05.2005","article-title":"Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease","volume":"25","author":"Kitazawa","year":"2005","journal-title":"J Neurosci"},{"key":"2024103012315473900_jphp13165-cit-0037","doi-asserted-by":"crossref","first-page":"8471","DOI":"10.1523\/JNEUROSCI.4654-15.2016","article-title":"APP regulates microglial phenotype in a mouse model of Alzheimer's disease","volume":"36","author":"Manocha","year":"2016","journal-title":"J Neurosci"},{"key":"2024103012315473900_jphp13165-cit-0038","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well-tolerated N-methyl-D-aspartate (NMDA) receptor antagonist\u2014a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacol"},{"key":"2024103012315473900_jphp13165-cit-0039","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N Engl J Med"},{"key":"2024103012315473900_jphp13165-cit-0040","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1517\/14656566.2010.493874","article-title":"Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease","volume":"11","author":"Bassil","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"2024103012315473900_jphp13165-cit-0041","doi-asserted-by":"crossref","first-page":"e0123289","DOI":"10.1371\/journal.pone.0123289","article-title":"Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis","volume":"10","author":"Matsunga","year":"2015","journal-title":"PLoS One"},{"key":"2024103012315473900_jphp13165-cit-0042","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/WAD.0000000000000261","article-title":"Memantine ER maintains patient response in moderate to severe Alzheimer's disease: post hoc analyses from a randomized, controlled, clinical trial of patients treated with cholinesterase inhibitors","volume":"32","author":"Grossberg","year":"2018","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2024103012315473900_jphp13165-cit-0043","first-page":"198","article-title":"Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug na\u00efve patients with mild-to-moderate Alzheimer's disease","volume":"1","author":"Peters","year":"2015","journal-title":"Alzheimers Dement"},{"key":"2024103012315473900_jphp13165-cit-0044","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3233\/JAD-143084","article-title":"Combination therapy of cholinesterase inhibitor (donepezil or galantamine) plus memantine in the Okayama Memantine Study","volume":"4","author":"Matsuzono","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"2024103012315473900_jphp13165-cit-0045","first-page":"323","article-title":"Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4\/4 genotype","volume":"84","author":"Liu","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024103012315473900_jphp13165-cit-0046","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1210\/jc.2003-030833","article-title":"Molecular changes underlying reduced pineal melatonin levels in Alzheimer's disease: alterations in preclinical and clinical stages","volume":"88","author":"Wu","year":"2003","journal-title":"J Clin Endocr Metab"},{"key":"2024103012315473900_jphp13165-cit-0047","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1034\/j.1600-079X.2003.00065.x","article-title":"Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels","volume":"35","author":"Zhou","year":"2003","journal-title":"J Pineal Res"},{"key":"2024103012315473900_jphp13165-cit-0048","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/07420529709001459","article-title":"Changes in endocrine circadian rhythms as markers of physiological and pathological brain aging","volume":"14","author":"Magri","year":"1997","journal-title":"Chronobiol Int"},{"key":"2024103012315473900_jphp13165-cit-0049","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0006-3223(97)00510-6","article-title":"Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking","volume":"45","author":"Mishima","year":"1999","journal-title":"Biol Psychiatry"},{"key":"2024103012315473900_jphp13165-cit-0050","first-page":"20","article-title":"The use of melatonin in Alzheimer's disease","volume":"23","author":"Cardinali","year":"2002","journal-title":"Neuro Endocrinol Lett"},{"key":"2024103012315473900_jphp13165-cit-0051","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1600-079X.2007.00491.x","article-title":"Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study","volume":"43","author":"Furio","year":"2007","journal-title":"J Pineal Res"},{"key":"2024103012315473900_jphp13165-cit-0052","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2006.07.049","article-title":"Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801","volume":"548","author":"Nakamura","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"2024103012315473900_jphp13165-cit-0053","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2353\/ajpath.2010.090452","article-title":"Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice","volume":"176","author":"Martinez-Coria","year":"2010","journal-title":"Am J Pathol"},{"key":"2024103012315473900_jphp13165-cit-0054","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jphp.12830","article-title":"Melatonin ameliorates A\u03b21-42 -induced Alzheimer's cognitive deficits in mouse model","volume":"70","author":"Gong","year":"2018","journal-title":"J Pharm Pharmacol"},{"key":"2024103012315473900_jphp13165-cit-0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1602\/neurorx.2.3.423","article-title":"Transgenic models of Alzheimer's disease: learning from animals","volume":"2","author":"Spires","year":"2005","journal-title":"Neurotherapeutics"},{"key":"2024103012315473900_jphp13165-cit-0056","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/jnr.21713","article-title":"Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging","volume":"86","author":"Scholtzova","year":"2008","journal-title":"J Neurosci Res"},{"key":"2024103012315473900_jphp13165-cit-0057","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2017.02.001","article-title":"Memantine reduces the production of amyloid-beta peptides through modulation of amyloid precursor protein trafficking","volume":"798","author":"Ito","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"2024103012315473900_jphp13165-cit-0058","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jnr.22172","article-title":"Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP\/PS1 transgenic mice","volume":"88","author":"Alley","year":"2010","journal-title":"J Neurosci Res"},{"key":"2024103012315473900_jphp13165-cit-0059","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bbrc.2017.09.058","article-title":"Memantine inhibits \u03b2-amyloid aggregation and disassembles preformed \u03b2-amyloid aggregates","volume":"493","author":"Takahashi-Ito","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"2024103012315473900_jphp13165-cit-0060","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2174\/1570159X15666170313123454","article-title":"Mechanisms of melatonin in alleviating Alzheimer's disease","volume":"15","author":"Shukla","year":"2017","journal-title":"Curr Neuropharm"},{"key":"2024103012315473900_jphp13165-cit-0061","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-079X.1999.tb00575.x","article-title":"Melatonin affects the metabolism of the beta-amyloid precursor protein in different cell types","volume":"26","author":"Lahiri","year":"1999","journal-title":"J of Pineal Res"},{"key":"2024103012315473900_jphp13165-cit-0062","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1074\/jbc.273.13.7185","article-title":"Inhibition of Alzheimer beta-fibrillogenesis by melatonin","volume":"273","author":"Pappolla","year":"1998","journal-title":"J Biol Chem"},{"key":"2024103012315473900_jphp13165-cit-0063","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s007020050018","article-title":"An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease","volume":"107","author":"Pappolla","year":"2000","journal-title":"J of Neural Transm"},{"key":"2024103012315473900_jphp13165-cit-0064","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuroscience.2011.02.045","article-title":"Mechanism of neuroprotection of melatonin against beta-amyloid neurotoxicity","volume":"180","author":"Ionov","year":"2011","journal-title":"Neuroscience"},{"key":"2024103012315473900_jphp13165-cit-0065","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.arcmed.2012.10.015","article-title":"Deregulated Cdk5 activity is involved in inducing Alzheimer's disease","volume":"43","author":"Shukla","year":"2012","journal-title":"Arch Med Res"},{"key":"2024103012315473900_jphp13165-cit-0066","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.neurobiolaging.2012.12.010","article-title":"Disease-modified glycogen synthase kinase-3\u03b2 intervention by melatonin arrests the pathology and memory deficits in an Alzheimer's animal model","volume":"34","author":"Peng","year":"2013","journal-title":"Neurobiol Aging"},{"key":"2024103012315473900_jphp13165-cit-0067","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/jpi.12260","article-title":"Melatonin regulates the transcription of \u03b2APP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells","volume":"59","author":"Panmanee","year":"2015","journal-title":"J Pineal Res"},{"key":"2024103012315473900_jphp13165-cit-0068","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0149-7634(98)00058-X","article-title":"Inflammatory pathogenesis in Alzheimer's disease: biological mechanisms and cognitive sequelae","volume":"23","author":"Gahtan","year":"1999","journal-title":"Neurosci Biobehav Rev"},{"key":"2024103012315473900_jphp13165-cit-0069","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jneuroim.2006.11.017","article-title":"Inflammatory processes in Alzheimer's disease","volume":"184","author":"Heneka","year":"2007","journal-title":"J Neuroimmunol"},{"key":"2024103012315473900_jphp13165-cit-0070","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/jnnp-2012-304644","article-title":"TDP-43 frontotemporal lobar degeneration and autoimmune disease","volume":"84","author":"Miller","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024103012315473900_jphp13165-cit-0071","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nn.3668","article-title":"Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors","volume":"17","author":"Crotti","year":"2014","journal-title":"Nat Neurosci"},{"key":"2024103012315473900_jphp13165-cit-0072","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.arr.2013.12.007","article-title":"The role of the inflammasome in Alzheimer's disease","volume":"15","author":"Liu","year":"2014","journal-title":"Ageing Res Rev"},{"key":"2024103012315473900_jphp13165-cit-0073","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0197-4580(95)00092-S","article-title":"Role of microglia in senile plaque formation","volume":"16","author":"Mackenzie","year":"1995","journal-title":"Neurobiol Aging"},{"key":"2024103012315473900_jphp13165-cit-0074","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.neuron.2013.05.007","article-title":"Microglia as dynamic and essential components of the amyloid hypothesis","volume":"78","author":"Gandy","year":"2013","journal-title":"Neuron"},{"key":"2024103012315473900_jphp13165-cit-0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/glia.22350","article-title":"Microglia and neurodegeneration: the role of systemic inflammation","volume":"61","author":"Cunningham","year":"2013","journal-title":"Glia"},{"key":"2024103012315473900_jphp13165-cit-0076","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/glia.20571","article-title":"Resident microglia die and infiltrated neutrophils and monocytes become major inflammatory cells in lipopolysaccharide-injected brain","volume":"55","author":"Ji","year":"2007","journal-title":"Glia"},{"key":"2024103012315473900_jphp13165-cit-0077","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuint.2014.06.012","article-title":"Mechanism of synapse redox stress in okadaic acid (ICV) induced memory impairment: role of NMDA receptor","volume":"76","author":"Kamat","year":"2014","journal-title":"Neurochem Int"},{"key":"2024103012315473900_jphp13165-cit-0078","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/157015910792246155","article-title":"Antiinflammatory activity of melatonin in central nervous system","volume":"8","author":"Esposito","year":"2010","journal-title":"Curr Neuropharmacol"},{"key":"2024103012315473900_jphp13165-cit-0079","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pneurobio.2015.02.001","article-title":"Melatonin and brain inflammaging","volume":"127\u2013128","author":"Hardeland","year":"2015","journal-title":"Prog Neurogibol"},{"key":"2024103012315473900_jphp13165-cit-0080","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1080\/10408398.2018.1487927","article-title":"Anti-inflammatory effects of melatonin: a mechanistic review","volume":"59","author":"Nabavi","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2024103012315473900_jphp13165-cit-0081","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0168-8278(03)00504-X","article-title":"Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats","volume":"40","author":"Bruck","year":"2004","journal-title":"J Hepatol"},{"key":"2024103012315473900_jphp13165-cit-0082","first-page":"641","article-title":"Effect of melatonin on cyclooxygenase-2 expression and nuclear factor kappa B activation in RAW264.7 macrophage-like cells stimulated with fimbriae of Porphyromonas gingivalis","volume":"25","author":"Murakami","year":"2011","journal-title":"In Vivo"},{"key":"2024103012315473900_jphp13165-cit-0083","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0009-2797(00)00319-7","article-title":"Melatonin reduces interleukin secretion in amyloid-beta stressed mouse brain slices","volume":"134","author":"Clapp-Lilly","year":"2001","journal-title":"Chem Biol Interact"},{"key":"2024103012315473900_jphp13165-cit-0084","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-079X.2008.00606.x","article-title":"Melatonin is able to prevent the liver of old castrated female rats from oxidative and pro-inflammatory damage","volume":"45","author":"Kireev","year":"2008","journal-title":"J Pineal Res"},{"key":"2024103012315473900_jphp13165-cit-0085","doi-asserted-by":"crossref","first-page":"9707","DOI":"10.1007\/s11357-014-9707-3","article-title":"Melatonin and oestrogen treatments were able to improve neuroinflammation and apoptotic processes in dentate gyrus of old ovariectomized female rats","volume":"36","author":"Kireev","year":"2014","journal-title":"Age (Dordr)"},{"key":"2024103012315473900_jphp13165-cit-0086","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann Transl Med"},{"key":"2024103012315473900_jphp13165-cit-0087","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1038\/npp.2008.53","article-title":"Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimer's disease","volume":"33","author":"Dong","year":"2008","journal-title":"Neuropsychopharmacol"},{"key":"2024103012315473900_jphp13165-cit-0088","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/srep00535","article-title":"Diosgenin is an exogenous activator of 1,25D3-MARRS\/Pdia3\/ERp57 and improves Alzheimer's disease pathologies in 5XFAD mice","volume":"2","author":"Tohda","year":"2012","journal-title":"Sci Rep"},{"key":"2024103012315473900_jphp13165-cit-0089","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-079X.2009.00692.x","article-title":"Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease","volume":"47","author":"Olcese","year":"2009","journal-title":"J Pineal Res"},{"key":"2024103012315473900_jphp13165-cit-0090","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuroscience.2013.01.059","article-title":"Effects of memantine and melatonin on signal transduction pathways vascular leakage and brain injury after focal cerebral ischemia in mice","volume":"237","author":"Kilic","year":"2013","journal-title":"Neuroscience"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jphp.13165","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jphp.13165","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/71\/11\/1695\/60224030\/jphp13165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/71\/11\/1695\/60224030\/jphp13165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T17:43:04Z","timestamp":1730310184000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/71\/11\/1695\/6122154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":90,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,1]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jphp.13165","relation":{},"ISSN":["2042-7158","0022-3573"],"issn-type":[{"value":"2042-7158","type":"electronic"},{"value":"0022-3573","type":"print"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,11,1]]}}}